Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Influenza Vaccine GHB11L1 Against Controlled Influenza Challenge in Healthy Adults
2009-011529-15Phase 2Terminated
- Sponsor
- Green Hills Biotechnology
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in influenza and Influenza A infection comparing GHB11L1 vaccine arm with Placebo arm (2 arms). Primary endpoint: Reduction of viral load after controlled influenza virus challenge. Started Oct 2009; status: terminated.
02
Drugs
GHB11L1
03
Conditions
influenzaInfluenza A infection
Beyond the preview
Go deeper on 2009-011529-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011529-15.